Mark Watson
Business Development & Corporate Development Leader - Companion Diagnostics (CDx) - BioPharma Services and Partnership Development
- Role
- Director of Business Development & Alliance Management - Companion Diagnostics (Cdx) at Agilent Technologies
- Location
- Germantown, MD, US
- LinkedIn followers
- 500 followers
About Mark Watson
Dynamic, experienced global business development and international marketing leader that combines an excellent understanding of strategic marketing with skill in technology management. An effective leader with diverse expertise in technical sales, competitive intelligence, product management, marketing program development, as well as purpose-driven team leadership within the sciences and high-tech industries.Specialties:*Business Development: Technology scouting, Opportunity assessment, Partnership strategy, High level negotiation of complex technology deals, and Solution selling * Marketing: Strategic marketing, Product management, Competitive intelligence, Business intelligence, International business, Market research, Marketing communications, and Media relations* Licensing: In/Out Licensing, Contracts, Deal Negotiation, Corporate development and Structuring of \"high value\" multi-million dollar deals and project budgets * Mergers & Acquisitions: Asset evaluation, due diligence, and partnership evaluation * Other: Innovation management, New product development and Product commercialization
Experience
Director of Business Development & Alliance Management - Companion Diagnostics (Cdx)
Sep 2018 — Present · Washington, DC, US
Global business development team lead responsible for BioPharma partnerships, CDx services and the establishment of effective revenue-generating relationships to develop, register, manufacture and commercialize companion diagnostics in parallel with pharmaceutical and biotechnology targeted therapy and personalized/precision medicine programs. Primary lead contributor that is responsible for generating, securing and driving continuous deal flow of attractive/strategic partnership opportunities that lead to high value agreements with an emphasis on agreements that cover pre-launch commercialization and launch activities that are executed by the Life Sciences and Diagnostics Market Group and commercial business channels such as the Pathology (Dako) and Genomics Divisions within Agilent.
Education
Harvard Law School
Professional Certification, Executive Program on Negotiation
2008 — 2009
Webster University
MBA, International Business and Business Administration
1996 — 1998
Morehouse College
BS, Biology
1987 — 1992
Bentley University - McCallum Graduate School of Business
MSIAM, Information Age Marketing & Technology
1999 — 2002
Skills
- Biochemistry
- Strategic Partnerships
- Glp
- Biotechnology
- Oncology
- Product Marketing
- Cell Biology
- Genetics
- Proteomics
- Drug Development
- Biopharmaceuticals
- Genomics
- Molecular Diagnostics
- Cell Culture
- Bioinformatics
- Cross-Functional Team Leadership
- Competitive Intelligence
- Marketing Strategy
- Dna
- Monoclonal Antibodies
- Immunology
- Assay Development
- Antibodies
- Protein Chemistry
- Product Management
- Strategic Planning
- Product Development
- Technology Transfer
- R&D
- Technology Evaluation
- High Throughput Screening
- Business Planning
- Drug Discovery
- Licensing
- Commercialization
- Molecular Biology
- Product Launch
- Market Research
- Business Development
- Medical Devices
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.